ロード中...
HCV kinetic and modeling analyses project shorter durations to cure under combined therapy with daclatasvir and asunaprevir in chronic HCV-infected patients
BACKGROUND & AIMS: High cure rates are achieved in HCV genotype-1b patients treated with daclatasvir and asunaprevir, DCV/ASV. Here we analyzed early HCV kinetics in genotype-1b infected Japanese subjects treated with DCV/ASV and retrospectively projected, using mathematical modeling, whether sh...
保存先:
| 出版年: | PLoS One |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Public Library of Science
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5720697/ https://ncbi.nlm.nih.gov/pubmed/29216198 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0187409 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|